Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-21
2006-02-21
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S204000, C548S217000
Reexamination Certificate
active
07001916
ABSTRACT:
Disclosed are epothilone compounds of formula I,which are useful as pharmaceutical compounds for treating, for example, malignant tumors and chronic inflammatory diseases and are useful in anti-angiogenesis therapy.
REFERENCES:
patent: 5469145 (1995-11-01), Johnson
patent: 6043372 (2000-03-01), Schinzer et al.
patent: 6156905 (2000-12-01), Schinzer et al.
patent: 6730699 (2004-05-01), Li et al.
patent: 2002/0058817 (2002-05-01), Danishefsky et al.
patent: 2004/0012735 (2004-01-01), Sato et al.
patent: 2004/0019088 (2004-01-01), Hoffman et al.
patent: 4138042 (1993-05-01), None
patent: 19636343 (1997-10-01), None
patent: 19701758 (1998-07-01), None
patent: WO 9719086 (1997-05-01), None
patent: WO 98/08849 (1998-03-01), None
patent: WO 98/25929 (1998-06-01), None
patent: WO 99/01124 (1999-01-01), None
patent: WO 99/02514 (1999-01-01), None
patent: WO 99/07692 (1999-02-01), None
patent: WO 99/67253 (1999-12-01), None
patent: 2001066154 (2001-09-01), None
patent: WO 01/66154 (2001-09-01), None
patent: 2004012735 (2004-02-01), None
patent: WO 2004015088 (2004-02-01), None
Ca 127:268036, “Water soluble paclitaxel prodrugs”, Li et al., U.S. Patent 6730699.
Ca 140:176348, “Transposon-based transformation system encoding a transposase and uses for mutagenesis”, Julien et al., WO 2004015088.
W. Clarke Still et al.: Tetradedron Letters, Bd. 21, 1980, Seiten 103-4, XP002095727.
K. A. Parker et al.: Journal of Organic Chemistry, Bd. 52, Nr. 19, 1987, Seiten 4369-77, XP002095726.
K. Tamao et al.: Journal of the Chemical Society, Chemical Communications, 1988, Seiten 795-7, XP002095725.
D. Schinzer et al.: Chemistry—A European Journal, Bd. 2, Nr. 11, 1996, Seiten 1477-82, XP002095724 in der Anmeldung erwaehnt.
K. C. Nicolaou et al.: Angewandte Chemie, Bd. 109, Nr. 19, 1997, Seiten 2181-7, XP002095723 in der Anmeldung erwaehnt.
K. C. Nicolaou et al.: Journal of the American Chemical Society, Bd. 119, Nr. 34, 1997, Seiten 7974-91, XP002095719 in der Anmeldung erwaehnt.
Ca Reference 132:293587, “The Olefin Metathesis Approach to Epothilone A and its Analogs”, Nicolau et al., p. 674, No. 22, Year 2000.
Nicolau et al., “Total Synthesis of Oxazole-and Cyclopropane-Cotaining Epothilone B Analogues by the Macrolactonization Approach”, pp. 1971-1986, Chem. Eur. J., vol. 3, No. 12, 1997.
U.S. Appl. No. 09/485,292.
U.S. Appl. No. 09/979,939.
Zhen Yang et al.: Angewandte Chemie, Bd. 109, Nr. 1/2, 1997, Seiten 170-2, XP002095722 in der Anmeldung erwaehnt.
K. C. Nicolaou et al.: Nature, Bd. 387, Nr. 6630, 15. Mai 1997, Seiten 268-72, XP002095721 in der Anmeldung erwaehnt.
D. Schinzer et al.: Angewandte Chemie, Bd. 109, Nr. 5, 1997, Seiten 543-4, XP002095720 in der Anmeldung erwaehnt.
K. C. Nicolaou: Journal of the American Chemical Society, Bd. 119, Nr. 34, 1997, Seiten 7960-73, XP002064442 in der Anmeldung erwaehnt.
K.C. Nicolaou et al.: “Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, And Cytotoxic Action Against Taxol.Resistant Tumor Cells” Angewandte Chemie. International Edition, DE. Verlag Chemie. Weinheim, vol. 36, No. 19, 1997, pp. 2097-2103, XP00206441.
K.C. Nicolaou et al.: “Chemical Biology of Epothilone” Angewandte Chemie, International Edition, De. Verlag Chemie. Weinheim, vol. 37, No. 15, Aug. 1998 pp. 2014-2045, XP002131418.
K.C. Nicolaou et al.: “Total Synthesis of Oxazole- and Cyclopropane-Containing Epothilone A Analogues by the Olefin Metathesis Approach”—Chem Eur. J. 1997, 3, No. 12, pp. 1957-1970.
Buchmann Bernd
Klar Ulrich
Schirner Michael
Schwede Wolfgang
Skuballa Werner
Chang Celia
Millen White Zelano & Branigan P.C.
Schering AG
LandOfFree
Epothilon derivatives, method for the production and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epothilon derivatives, method for the production and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epothilon derivatives, method for the production and the use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3633463